Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BRODALUMAB Cause C-reactive protein increased? 19 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 19 reports of C-reactive protein increased have been filed in association with BRODALUMAB (Siliq). This represents 0.9% of all adverse event reports for BRODALUMAB.

19
Reports of C-reactive protein increased with BRODALUMAB
0.9%
of all BRODALUMAB reports
10
Deaths
15
Hospitalizations

How Dangerous Is C-reactive protein increased From BRODALUMAB?

Of the 19 reports, 10 (52.6%) resulted in death, 15 (78.9%) required hospitalization, and 10 (52.6%) were considered life-threatening.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BRODALUMAB. However, 19 reports have been filed with the FAERS database.

What Other Side Effects Does BRODALUMAB Cause?

Psoriasis (418) Drug ineffective (177) Arthralgia (175) Fatigue (152) Psoriatic arthropathy (141) Intentional product use issue (136) Headache (126) Therapy interrupted (126) Product dose omission issue (124) Disease recurrence (118)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which BRODALUMAB Alternatives Have Lower C-reactive protein increased Risk?

BRODALUMAB vs BROLUCIZUMAB BRODALUMAB vs BROLUCIZUMAB-DBLL BRODALUMAB vs BROMAZEPAM BRODALUMAB vs BROMFENAC BRODALUMAB vs BROMHEXINE

Related Pages

BRODALUMAB Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased BRODALUMAB Demographics